Cardiovascular morbidity and mortality after liver transplantation: The protective role of mycophenolate mofetil

Delia D'Avola, Valentín Cuervas‐Mons, Josep Martí, Jorge Ortiz de Urbina, Laura Lladó, Carlos Jimenez, Esteban Otero, Francisco Suarez, Juan M. Rodrigo, Miguel‐Angel Gómez, Enrique Fraga, Pedro Lopez, M. Trinidad Serrano, Antonio Rios, Emilio Fábrega, José Ignacio Herrero – 3 February 2017 – Cardiovascular (CV) diseases are recognized longterm causes of death after liver transplantation (LT). The objective of this multicenter study was to analyze the prevalence and the evolution of CV risk factors and CV morbidity and mortality in 1819 LT recipients along 5 years after LT.

Subscribe to